United States Water Treatment Chemicals Market Outlook to 2030: Size, Share, Growth and Trends

The United States Water Treatment Chemicals Market is valued at USD 8,320 Mn in 2024 , and the base year is measured on an industry revenue basis at the manufacturer or formulator level. That means the number reflects ex-factory sales to municipal utilities, industrial end-users, and distributors, rather than distributor resale value or equipment revenue. The base year also includes all major U.S. regions and the full seven-product sizing spine, making it appropriate for investment screening, portfolio benchmarking, and pricing strategy. It is a revenue pool view, not a capex market or a treatment-plant construction market.

The market is projected to grow from USD 8,320 Mn in 2024 to USD 11,490 Mn by 2030 , implying a 5.5% CAGR over 2025-2030 . This is faster than the implied 4.3% CAGR over 2019-2024 , which indicates that the next phase is being accelerated by regulation and mix shift rather than simple post-pandemic normalization. The most important implication is that value growth slightly outpaces volume growth because premium chemistries, PFAS treatment, corrosion control, and digitally monitored programs are taking a larger share of procurement budgets.

The largest absolute revenue pool remains in coagulants and flocculants, but the most attractive profit shift is toward specialty and compliance-intensive chemistries. Coagulants and flocculants account for 31.8% of 2024 revenue , while specialty and emerging chemicals hold only 7.2% today, leaving room for disproportionate expansion. Biocides and disinfectants are the fastest-growing major segment at 6.1% CAGR , supported by tighter microbiological control requirements and higher sensitivity to plant uptime and public-health compliance. Over time, that mix shift should improve average revenue per tonne and strengthen technical-service attachment rates.

The main structural risk is uneven customer economics across a very fragmented utility base combined with rising regulatory complexity. EPA reports more than 148,000 public water systems in the United States, and many smaller systems cannot move quickly into treatment upgrades without financing, consolidation, or technical assistance. At the same time, PFAS regulation and chemical reporting rules raise qualification, documentation, and liability demands. This means growth is available, but not every account will monetize at the same pace, and suppliers without technical support capability may struggle to convert regulatory interest into durable revenue.

The United States ranks first among the selected peer group and is materially larger than Japan, Germany, Canada, and Mexico in current market size. At USD 8,320 Mn in 2024 , it represents about 67.0% of the selected peer-set revenue pool used in this report. Its growth profile at 5.5% CAGR is stronger than mature industrial peers such as Japan and Germany, although Mexico grows faster from a smaller base. The U.S. advantage comes from the combination of a large regulated utility network, industrial water intensity, and unusually strong federal infrastructure support.

The strongest long-term demand driver is the sheer scale of the installed water-treatment base, not a single short-cycle end market. More than 320 million people are served by community water systems, and U.S. wastewater facilities process roughly 34 billion gallons per day . That installed base creates recurring chemical consumption independent of new-build cycles. Regulatory waves such as PFAS and lead service line replacement then add value on top of that recurring foundation. For management teams, this means the market has both defensive demand characteristics and a visible compliance-driven upgrade cycle.